Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.074x

Based on the latest financial reports, Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) has a cash flow conversion efficiency ratio of 0.074x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥502.01 Million ≈ $73.46 Million USD) by net assets (CN¥6.75 Billion ≈ $987.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603707 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Nanjing King-friend Biochemical Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanjing King-friend Biochemical Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
German American Bancorp Inc NASDAQ:GABC	0.032x
Shenzhen JingQuanHua Electronics Co Ltd SHE:002885	0.013x
WeRide Inc. American Depositary Shares NASDAQ:WRD	0.022x
Fibra Terrafina MX:TERRA13	0.027x
Saurer Intelligent Technology Co Ltd Class A SHG:600545	-0.003x
TBO Tek Ltd NSE:TBOTEK	0.021x
Tien Phong Commercial Joint Stock Bank VN:TPB	0.690x
Deterra Royalties Ltd AU:DRR	0.623x

Annual Cash Flow Conversion Efficiency for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Nanjing King-friend Biochemical Pharmaceutical Co Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Nanjing King-friend Biochemical Pharmace worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.90 Billion ≈ $1.01 Billion	CN¥1.18 Billion ≈ $173.08 Million	0.171x	-25.91%
2024-12-31	CN¥6.49 Billion ≈ $949.42 Million	CN¥1.50 Billion ≈ $219.68 Million	0.231x	-17.14%
2023-12-31	CN¥5.80 Billion ≈ $848.50 Million	CN¥1.62 Billion ≈ $236.94 Million	0.279x	+189.21%
2022-12-31	CN¥6.17 Billion ≈ $902.45 Million	CN¥595.45 Million ≈ $87.13 Million	0.097x	-23.70%
2021-12-31	CN¥5.40 Billion ≈ $790.59 Million	CN¥683.63 Million ≈ $100.04 Million	0.127x	+183.74%
2020-12-31	CN¥3.74 Billion ≈ $547.95 Million	CN¥-565.85 Million ≈ $-82.80 Million	-0.151x	+46.05%
2019-12-31	CN¥3.00 Billion ≈ $439.59 Million	CN¥-841.38 Million ≈ $-123.12 Million	-0.280x	-1187.25%
2018-12-31	CN¥2.42 Billion ≈ $354.28 Million	CN¥62.37 Million ≈ $9.13 Million	0.026x	+122.54%
2017-12-31	CN¥2.05 Billion ≈ $300.31 Million	CN¥-234.59 Million ≈ $-34.33 Million	-0.114x	+47.60%
2016-12-31	CN¥1.31 Billion ≈ $192.37 Million	CN¥-286.79 Million ≈ $-41.97 Million	-0.218x	-273.64%
2015-12-31	CN¥1.09 Billion ≈ $159.89 Million	CN¥137.28 Million ≈ $20.09 Million	0.126x	-27.47%
2014-12-31	CN¥1.03 Billion ≈ $150.99 Million	CN¥178.74 Million ≈ $26.16 Million	0.173x	-9.03%
2013-12-31	CN¥1.02 Billion ≈ $149.02 Million	CN¥193.91 Million ≈ $28.38 Million	0.190x	--

About Nanjing King-friend Biochemical Pharmaceutical Co Ltd

SHG:603707 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.69 Billion

CN¥11.54 Billion CNY

Market Cap Rank

#6864 Global

#1531 in China

Share Price

CN¥7.14

Change (1 day)

+0.28%

52-Week Range

CN¥7.08 - CN¥11.94

All Time High

CN¥33.62